Precaval recurrent endometrial cancer treated with en-bloc resection of the inferior vena cava and reconstruction using bovine pericardium. A case report and review of the literature.

Bovine Pericardium Inferior vena cava reconstruction Para-aortic lymph nodes Precaval lymph nodes Recurrent endometrial cancer Secondary cytoreduction

Journal

Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 10 08 2020
revised: 16 11 2020
accepted: 21 11 2020
entrez: 11 12 2020
pubmed: 12 12 2020
medline: 12 12 2020
Statut: epublish

Résumé

•Bovine pericardium for IVC reconstruction has significant advantages comparing to vascular ligation, autogenous or PTFE grafts.•En-bloc resection of metastatic precaval lymph nodes and reconstruction of the IVC is feasible.•Recurrence of endometrial cancer at para-aortic lymph nodes is good candidate for secondary cytoreduction with MDT approach.

Identifiants

pubmed: 33304980
doi: 10.1016/j.gore.2020.100679
pii: S2352-5789(20)30145-4
pmc: PMC7718161
doi:

Types de publication

Case Reports

Langues

eng

Pagination

100679

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Gynecol Oncol. 2010 Jul;118(1):14-8
pubmed: 20434198
Urology. 2019 Dec;134:143-147
pubmed: 31542462
Gynecol Oncol. 2010 Oct;119(1):167-8
pubmed: 20609465
Ann Thorac Surg. 2015 Mar;99(3):831-7
pubmed: 25583467
Gynecol Oncol. 2015 Dec;139(3):580-1
pubmed: 26475961
Int J Gynecol Cancer. 2020 Feb;30(2):193-200
pubmed: 31792085
Physiol Res. 2009;58 Suppl 2:S119-39
pubmed: 20131930
Eur J Gynaecol Oncol. 2014;35(5):535-8
pubmed: 25423699
J Thorac Dis. 2017 Apr;9(4):E367-E372
pubmed: 28523180
Ann Vasc Surg. 2011 May;25(4):561-8
pubmed: 21276709

Auteurs

Huan Xie (H)

Sydney Gynaecologic Oncology Group, Chris O Brien Lifehouse Comprehensive Cancer Centre and Royal Prince Alfred Hospital, Camperdown, Sydney, Australia.

Selvan Pather (S)

Sydney Gynaecologic Oncology Group, Chris O Brien Lifehouse Comprehensive Cancer Centre and Royal Prince Alfred Hospital, Camperdown, Sydney, Australia.
The University of Sydney School of Medicine, Sydney, Australia.

David Yeo (D)

Department of Upper Gastrointestinal Surgery, Chris O Brien Lifehouse Comprehensive Cancer Centre and Royal Prince Alfred Hospital, Camperdown, Sydney, Australia.

Gaithri Mylvaganam (G)

Sydney Gynaecologic Oncology Group, Chris O Brien Lifehouse Comprehensive Cancer Centre and Royal Prince Alfred Hospital, Camperdown, Sydney, Australia.

Rasa Venclovas (R)

Department of Anaesthesiology, Chris O Brien Lifehouse Comprehensive Cancer Centre and Royal Prince Alfred Hospital, Camperdown, Sydney, Australia.

Lyndal Anderson (L)

Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
The University of Sydney School of Medicine, Sydney, Australia.

Classifications MeSH